« Back
Home /
AKT inhibitor VIII

AKT inhibitor VIII

Item no.	TMO-T3346-50mg
Manufacturer	TargetMol
CASRN	612847-09-3
Amount	50 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category	Neuroscience Metabolism Diabetes Aging & Neurological Disorders Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. Lindsley CW, et al. Bioorg Med Chem Lett. 2005, 15(3), 761-764.
Smiles	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(cc2)-c2nc3cc4[nH]cnc4cc3nc2-c2ccccc2)CC1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	AKTi-1/2
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Apoptosis\|\|\|Akt
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	551.64
Description	AKT inhibitor VIII (AKTi-1/2) is a highly specific inhibitor of Akt1/2, with IC50 values of 58 nM and 210 nM respectively, demonstrating approximately 36-fold greater selectivity for Akt1 over Akt3.
Pathways	Apoptosis\|\|\|PI3K/Akt/mTOR signaling\|\|\|Cytoskeletal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T3346-50mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question